Stocks To Buy Now

Blog


Social Media Strategies Summit, Senior Level Marketing – Virtual Event

Social media enthusiasts, strategists, content creators, and business owners, are all invited to attend the virtual Social Media Strategies Summit, Senior Level Marketing event. The event will be held from October 23, 2024, through October 25, 2024. Top industry leaders will be there to share detailed strategies for helping brands grow and succeed. The event will cover every aspect that affects a brand’s social media presence. Acknowledged professionals like Maya Wasserman and David Velez will address participants, with every session uniquely designed for an overall holistic approach.

Why Attend?

  • Understand the fundamentals of groundbreaking strategies that provide success to a brand.
  • Scrutinize the brand’s efficacy to stay competitive and relevant.
  • Gain unique insights and expertise on a range of important topics.
  • Access to cross-industry case studies.
  • Learn how to understand and define your audience better.
  • Make use of a variety of tools and resources to create relevant and fresh strategies time and again.

With more than 20 senior-level executive leaders as speakers, this forum aims to offer comprehensive and robust social media strategies. Industry experts such as Maya Wasserman (Sony), David Velez (Amazon Web Services), and Katie Yun (Nationwide) will offer key points to success.

The pre-summit will be held on October 23, where seasoned trainers Efri Dereje (Senior Marketing Manager at Gebeya) and Brenton Thomas (Founder of Twibi) will hold small-group 3-hour sessions and conduct workshops on content creation and GA4 and GTM. This pre-summit can be added to the general summit registration for an additional fee.

The Social Media Strategies Summit is virtual, allowing participants from across the globe to gather proficiency and boost their related businesses and services.

To learn more, please visit https://ibn.fm/SbZUp

From Our Blog

Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

April 9, 2026

Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of […]

Rotate your device 90° to view site.